排序方式: 共有1条查询结果,搜索用时 0 毫秒
1
1.
Friyana K. Bhabha MBBS FACD Christopher McCormack MBBS FACD Belinda A. Campbell MBBS MMed FRANZCR Stephen Lade MBBS FRCPA Odette Buelens RN BN PGDipNur MN NP Carrie Van Der Weyden MBBS FRACP FRCPA H. Miles Prince MBBS MD FRACP FRCPA AFRCMA MACD FAHMS 《The Australasian journal of dermatology》2023,64(2):194-203
The CD30-postive lymphoproliferative disorders, including lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma, account for up to 30% of all cutaneous T-cell lymphomas (CTCLs) and are the second most common form of CTCLs after mycosis fungoides. Both conditions differ in their clinical presentations; however, they share the expression of the CD30 antigen as a common immunophenotypic hallmark. There is a wide spectrum of management options depending on factors such as extent of disease, staging and treatment tolerability. This Clinical Practice Statement is reflective of the current clinical practice in Australia. 相似文献
1